openPR Logo
Press release

Respiratory syncytial virus (RSV) Diagnostic Market is dominated by North America and Europe

03-02-2020 04:16 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Respiratory Syncytial Virus (RSV) Diagnostic Market

Respiratory Syncytial Virus (RSV) Diagnostic Market

According to a new report published by Allied Market Research, titled, "World Respiratory Syncytial Virus (RSV) Diagnostic Market - Opportunities and Forecasts, 2019-2026"
The global market size of Respiratory Syncytial Virus (RSV) Diagnostic Market is $XX million in 2020 with XX CAGR, and it is expected to reach $XX million by the end of 2026 with a CAGR of XX% from 2020 to 2027.

Click Here To Access Free Sample Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/270

Some of the key players in this market are Abott Laboratories, Becton Dickinson and Company, bioMerieux, Bio-Rad Laboratories, Beckman Coulter Thermo Fisher Scientific and EMD Millipore. In 2001, Abott and IntelligentMDx (IMDX) entered into an agreement in which IMDx would develop and design real time PCR assays for the Abott m2000 instrument system. The IMDx Flu A/B and RSV test is one such test developed by IntelligentMDx (IMDX) of Cambridge, for Abbott's m2000 molecular diagnostics system. The test is a qualitative Reverse Transcription test for rapid detection of different strains of RSV as well Influenza A, and Influenza B. The test could analyze 94 samples per run and it is fully automated with minimal turnaround time.

KEY BENEFITS
o In depth analysis of current technologies used in the RSV diagnostic enables strategic decision making by stakeholders
o Identification of drivers, restraints and opportunities in the market
o Market segmentation based on technology, end users and geography helps in exploring new business opportunities.
o Analysis of the key players in the market and the technologies developed by them would help in understanding strategies implemented by the competitors

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/270

KEY DELIVERABLES
The RSV diagnostic market is segmented based on technology, end users and geographic distribution.
RSV Diagnostic Market by Technology
o Molecular Diagnostics
o Monoclonal Antibodies
o Immunoassays
o Differential Light Scattering
o Artificial Intelligence
o Liposomes
o Flow Cytometry
o Chromatography
o Diagnostic Imaging
o Gel Microdroplets

RSV Diagnostic Market by End Users
o Hospitals
o Nursing homes
o Commercial Laboratories
o Public Health Laboratories

The RSV Diagnostic Market by Geographic Distribution
o North America
o Europe
o Asia Pacific
o Rest of the World

Obtain Report Details: https://www.alliedmarketresearch.com/respiratory-syncytial-virus-RSV-diagnostic-market

Related Reports:
In Vitro Diagnostics (IVD) Quality Control Product Market
https://www.alliedmarketresearch.com/ivd-in-vitro-diagnostics-quality-control-product-market

Protein Labeling Market
https://www.alliedmarketresearch.com/protein-labeling-market

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Life Science Market: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Respiratory syncytial virus (RSV) Diagnostic Market is dominated by North America and Europe here

News-ID: 1951529 • Views: 390

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for RSV

RSV Diagnostics Market | Pin-Point Analysis for Changing Competitive Dynamics
Human respiratory syncytial virus (RSV) is a virus that commonly causes lower respiratory tract infection. Human respiratory syncytial virus infections are acquired during hospital visits. Infants and in young children are more prone to human respiratory syncytial virus (RSV) infection. RSV infections affect lungs and respiratory tract of an individual. In premature babies and children with previous presence of diseases, RSV infections affect heart and immune systems as well resulting
Human Respiratory Syncytial Virus (RSV) Treatment Market to Rear Excessive Growt …
A syncytial virus is a multi-nucleated virus which results from multiple cell fusions. Human respiratory syncytial virus (RSV) has a size of around 120 to 200 nm and is an enveloped virus with a linear minus-sense RNA genome. Human respiratory syncytial virus (RSV) causes complications such as bronchiolitis, asthma, chronic respiratory tract infections and acute otitis media in patients. Human respiratory syncytial virus (RSV) infects the lungs and breathing passages.
Human Respiratory Syncytial Virus (RSV) Treatment Market Insights and Analysis f …
A syncytial virus is a multi-nucleated virus which results from multiple cell fusions. Human respiratory syncytial virus (RSV) has a size of around 120 to 200 nm and is an enveloped virus with a linear minus-sense RNA genome. Human respiratory syncytial virus (RSV) causes complications such as bronchiolitis, asthma, chronic respiratory tract infections and acute otitis media in patients. Human respiratory syncytial virus (RSV) infects the lungs and breathing passages.
RSV Diagnostics Market Trend | Industry Analysis Report, 2019
Human respiratory syncytial virus (RSV) is a virus that commonly causes lower respiratory tract infection. Human respiratory syncytial virus infections are acquired during hospital visits. Infants and in young children are more prone to human respiratory syncytial virus (RSV) infection. RSV infections affect lungs and respiratory tract of an individual. In premature babies and children with previous presence of diseases, RSV infections affect heart and immune systems as well resulting
RSV Diagnostics Market Set to Surge Significantly During 2019
Human respiratory syncytial virus (RSV) is a virus that commonly causes lower respiratory tract infection. Human respiratory syncytial virus infections are acquired during hospital visits. Infants and in young children are more prone to human respiratory syncytial virus (RSV) infection. RSV infections affect lungs and respiratory tract of an individual. In premature babies and children with previous presence of diseases, RSV infections affect heart and immune systems as well resulting
Detailed examination of Respiratory Syncytial Virus (RSV) Infections Global Clin …
"The Report Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H2, 2016 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" GlobalData's clinical trial report, Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H2, 2016" provides an overview of Respiratory Syncytial Virus (RSV) Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Respiratory Syncytial